// App-Quantinova.ai

TP184 2016 ASA : Did Race Impact Risk Factor Control in the SAMMPRIS Trial?

Researchers

Presenter

  • Tanya N. Turan

Principal Investigators

  • George A Cotsonis

  • Michael Lynn

  • Oscar Benavente

  • Colin P Derdeyn

  • David Fiorella

  • Bethany F Lane

  • Jean Montgomery

  • Scott L Janis

  • Marc I Chimowitz

Medical Centers

  • The University of British Columbia, Vancouver, BC, Canada

  • Emory University, Atlanta, GA

  • NIH/NIMHD, Bethesda, MD

  • SUNY at Buffalo Sch of Med, Stony Brook, NY

  • Medcl Univ of South Carolina, Charleston, SC

  • Washington Univ., Saint Louis, MO.

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Coronary Artery Disease

  • Stroke

Biomarkers

  • Sex hormone binding globulin

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim